NervGen President and CEO Mike Kelly discusses the potential of the company’s investigational drug NVG-291 for spinal cord injury.

CPHI Milan 2024, the premier global event for pharmaceutical professionals, will take place October 8-10 at Fiera Milano.

Miltenyi Biotec explains how a platform CMC approach helps companies get their cell or gene therapy to IND submission faster.

Digitalization can transform the operation and performance of the cell and gene therapy manufacturing space, to the benefit of all.

We dive into the archive of 2021 for insight and inspiration – this time with Sandy Macrae.

Researchers purchase Ozempic online and test for authenticity. Yes, it was counterfeit.

A panel of experts discuss the trends and innovations in the viral vector-based therapy sector at the ASGCT.

Check out our video interview with Debra Weiss from the Bill & Melinda Gates Medical Research Institute.

The transportation, storage, and administration of drugs in space: a hypothesis and the case for lyophilization

We dive into the archive of 2020 for insight and inspiration – this time with Anne Phelan.